Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Dow
Harvard Business School
Johnson and Johnson
Mallinckrodt

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Scherer Labs Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SCHERER LABS, and what generic and branded alternatives to SCHERER LABS drugs are available?

SCHERER LABS has six approved drugs.



Summary for Scherer Labs
US Patents:0
Tradenames:6
Ingredients:4
NDAs:6

Drugs and US Patents for Scherer Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scherer Labs CODEINE, ASPIRIN, APAP FORMULA NO. 2 acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 085640-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Scherer Labs PREDNISONE prednisone TABLET;ORAL 080371-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Scherer Labs CODEINE, ASPIRIN, APAP FORMULA NO. 4 acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 085638-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Scherer Labs MEPROBAMATE meprobamate TABLET;ORAL 083343-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Scherer Labs QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 085068-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Scherer Labs CODEINE, ASPIRIN, APAP FORMULA NO. 3 acetaminophen; aspirin; codeine phosphate CAPSULE;ORAL 085639-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Harvard Business School
Moodys
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.